Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FSPG PET/CT Imaging for Cancer Patients
NCT02599194Phase 2Completed
- Sponsor
- Andrei Iagaru
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Florilglutamic acid F-18 in breast cancer, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), mesothelioma, B-cell neoplasm, sponsored by Andrei Iagaru. Started Jul 2015; status: completed.
02
Drugs
Florilglutamic acid F-18
03
Conditions
breast cancernon-small cell lung cancer (NSCLC)renal cell carcinoma (RCC)mesotheliomaB-cell neoplasm
Beyond the preview
Go deeper on NCT02599194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02599194.